Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0725
-0.0045 (-5.84%)
Apr 28, 2026, 3:28 PM EST
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$513,903
Market Cap
457.24K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CNBX Pharmaceuticals | 1 |
| Actavia Life Sciences | 1 |
| Bio-Path Holdings | 1 |
| Eloxx Pharmaceuticals | 10 |
| Emmaus Life Sciences | 33 |
| Hepion Pharmaceuticals | 2 |
Altamira Therapeutics News
- 16 days ago - Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis - Accesswire
- 4 weeks ago - Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results - Accesswire
- 5 weeks ago - Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements - Accesswire
- 2 months ago - Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray - Accesswire
- 3 months ago - Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit - Accesswire
- 4 months ago - Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China - Accesswire
- 5 months ago - Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation - Accesswire
- 6 months ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules - Accesswire